{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:32:45Z","timestamp":1773779565694,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jgo.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T23:38:18Z","timestamp":1593214698000},"page":"1210-1216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of older and frail patients with multiple myeloma in the Portuguese routine clinical practice: Deliberations and recommendations from an expert panel of hematologists"],"prefix":"10.1016","volume":"11","author":[{"given":"Cristina","family":"Jo\u00e3o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Geraldes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rio","family":"Mariz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2020.06.002_bb0005","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an international Myeloma working group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2020.06.002_bb0010","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple Myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2020.06.002_bb0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1200\/EDBK_175171","article-title":"Myeloma in elderly patients: when less is more and more is more","author":"Rosko","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.jgo.2020.06.002_bb0020","unstructured":"GLOBOCAN. Cancer Today Population Factsheets. n.d."},{"key":"10.1016\/j.jgo.2020.06.002_bb0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/CCO.0000000000000395","article-title":"Elderly patients with multiple myeloma: towards a frailty approach?","volume":"29","author":"Zweegman","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0030","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/s41375-018-0142-9","article-title":"Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma network (EMN)","volume":"32","author":"Larocca","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.jgo.2020.06.002_bb0035","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3324\/haematol.2016.148189","article-title":"Geriatric assessment in multiple myeloma patients: validation of the international Myeloma working group (IMWG) score and comparison with other common comorbidity scores","volume":"101","author":"Engelhardt","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.06.002_bb0040","article-title":"Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989","volume":"46","author":"Schaapveld","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.jgo.2020.06.002_bb0045","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1634\/theoncologist.2011-0229","article-title":"Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data","volume":"16","author":"Pulte","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2020.06.002_bb0050","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/leu.2016.380","article-title":"Trends in overall survival and costs of multiple myeloma, 2000-2014","volume":"31","author":"Fonseca","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jgo.2020.06.002_bb0055","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2012.075051","article-title":"Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials","volume":"98","author":"Bringhen","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.06.002_bb0060","unstructured":"Multiple Myeloma: ESMO Clinical Practice Guidelines | ESMO n.d. https:\/\/www.esmo.org\/Guidelines\/Haematological-Malignancies\/Multiple-Myeloma (accessed July 22, 2019)."},{"key":"10.1016\/j.jgo.2020.06.002_bb0065","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bbmt.2015.08.005","article-title":"Autologous transplantation in elderly multiple Myeloma patients: is the procedure cost effective?","volume":"21","author":"Gay","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jgo.2020.06.002_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00277-018-3528-x","article-title":"Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma","volume":"98","author":"Marini","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0075","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3324\/haematol.2016.150334","article-title":"Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study","volume":"101","author":"Garderet","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.06.002_bb0080","unstructured":"Defining the Elderly | OncologyPRO n.d. https:\/\/oncologypro.esmo.org\/Education-Library\/Handbooks\/Cancer-in-the-Senior-Patient\/Chapter-01-Introduction (accessed July 22, 2019)."},{"key":"10.1016\/j.jgo.2020.06.002_bb0085","unstructured":"World Health Organization, Elderly population. SEARO n.d. http:\/\/www.searo.who.int\/health_situation_trends\/data\/chi\/elderly-population\/en\/ (accessed July 22, 2019)."},{"key":"10.1016\/j.jgo.2020.06.002_bb0095","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised Myeloma comorbidity index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"102","author":"Engelhardt","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.06.002_bb0100","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ajh.24532","article-title":"N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma","volume":"91","author":"Milani","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0105","unstructured":"MYELOMA Frailty score calculator n.d. http:\/\/www.myelomafrailtyscorecalculator.net\/ (accessed July 30, 2019)."},{"key":"10.1016\/j.jgo.2020.06.002_bb0110","unstructured":"Revised Myeloma Comorbidity Index (R-MCI) n.d. http:\/\/www.myelomacomorbidityindex.org\/en_calc.html (accessed July 30, 2019)."},{"key":"10.1016\/j.jgo.2020.06.002_bb0115","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2352-3026(18)30220-5","article-title":"A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma research Alliance risk profile): a development and validation study","volume":"6","author":"Cook","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0120","article-title":"A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial","author":"Facon","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jgo.2020.06.002_bb0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMsa012528","article-title":"Understanding the treatment preferences of seriously ill patients","volume":"346","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2020.06.002_bb0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1182\/asheducation-2017.1.212","article-title":"Fixed duration vs continuous therapy in multiple myeloma","volume":"2017","author":"Ludwig","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jgo.2020.06.002_bb0135","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/14737140.2018.1490181","article-title":"Maintenance and continuous therapy for multiple myeloma","volume":"18","author":"Richardson","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jgo.2020.06.002_bb0140","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/asheducation-2017.1.508","article-title":"Management of multiple myeloma in the relapsed\/refractory patient","volume":"2017","author":"Sonneveld","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jgo.2020.06.002_bb0145","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1200\/JCO.2014.60.2466","article-title":"Continuous therapy versus fixed duration of therapy in patients with newly diagnosed multiple Myeloma","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0150","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2017-07-795047","article-title":"Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma","volume":"131","author":"Facon","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2020.06.002_bb0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3324\/haematol.2018.200881","article-title":"Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life","volume":"104","author":"Greil","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.06.002_bb0160","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.3324\/haematol.2018.189969","article-title":"Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I\/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)","volume":"103","author":"Waldschmidt","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jgo.2020.06.002_bb0165","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00277-019-03640-y","article-title":"Multiple myeloma in elderly patients-a Portuguese multicentric real-life study","volume":"98","author":"Jo\u00e3o","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(16)31594-X","article-title":"Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial","volume":"389","author":"Durie","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2020.06.002_bb0185","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jpainsymman.2017.04.012","article-title":"Is early palliative care feasible in patients with multiple Myeloma?","volume":"54","author":"Porta-Sales","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jgo.2020.06.002_bb0190","unstructured":"WHO, WHO Definition of Palliative Care. WHO n.d. https:\/\/www.who.int\/cancer\/palliative\/definition\/en\/ (accessed July 24, 2019)."},{"key":"10.1016\/j.jgo.2020.06.002_bb0195","doi-asserted-by":"crossref","DOI":"10.5402\/2011\/815013","article-title":"Multiple Myeloma and diabetes","volume":"2011","author":"Issa","year":"2011","journal-title":"ISRN Endocrinol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0200","first-page":"15","article-title":"Expect psychiatric side effects from corticosteroid use in the elderly","volume":"63","author":"Cerullo","year":"2008","journal-title":"Geriatrics"},{"key":"10.1016\/j.jgo.2020.06.002_bb0205","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.7150\/jca.24288","article-title":"Multiple Myeloma index for risk of infection","volume":"9","author":"V","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.jgo.2020.06.002_bb0210","author":"Dire\u00e7\u00e3o-Geral da Sa\u00fade"},{"key":"10.1016\/j.jgo.2020.06.002_bb0215","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2011.08574.x","article-title":"Guidelines for supportive care in multiple myeloma 2011","volume":"154","author":"Snowden","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgo.2020.06.002_bb0220","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpainsymman.2011.06.019","article-title":"Content development for the functional assessment of Cancer therapy-multiple Myeloma (FACT-MM): use of qualitative and quantitative methods for scale construction","volume":"43","author":"Wagner","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jgo.2020.06.002_bb0225","unstructured":"The Portuguese Health Data Platform (PDS) - EPSA - European Public Sector Award n.d. https:\/\/www.epsa-projects.eu\/index.php\/The_Portuguese_Health_Data_Platform_(PDS)#tab=Case_description (accessed July 30, 2019)."},{"key":"10.1016\/j.jgo.2020.06.002_bb0230","unstructured":"Plataforma de Dados de Sa\u00fade (PDS) n.d. http:\/\/www.rcc.gov.pt\/Directorio\/Temas\/ServicosCidadao\/Paginas\/Plataforma-de-Dados-de-Sa%C3%BAde-(PDS).aspx (accessed July 30, 2019)."},{"issue":"Suppl","key":"10.1016\/j.jgo.2020.06.002_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1188\/13.CJON.S2.25-32","article-title":"Caregivers of multiple myeloma survivors","volume":"17","author":"Kurtin","year":"2013","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jgo.2020.06.002_bb0240","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1188\/10.CJON.E24-E39","article-title":"An update on the treatment of myelodysplastic syndromes","volume":"14","author":"Kurtin","year":"2010","journal-title":"Clin J Oncol Nurs"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406820300989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406820300989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:52:25Z","timestamp":1761817945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406820300989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1879406820300989"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2020.06.002","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of older and frail patients with multiple myeloma in the Portuguese routine clinical practice: Deliberations and recommendations from an expert panel of hematologists","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}